4. Segment Information and Concentrations (Tables)

9 Months Ended

Mar. 31, 2013

Segment Reporting [Abstract]

Segment Information

Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments		Bioprocessing Systems			Corporate and Other		Consolidated
Three months ended March 31, 2013
Net Sales	$	1,229,800	$	360,600	$	35,700		$	-	$	1,626,100
Foreign Sales		645,300		107,300		-			-		752,600
Profit (Loss)		243,300		3,600		(41,700	)		-		205,200
Assets		2,719,500		1,932,600		904,600			916,800		6,473,500
Long-Lived Asset Expenditures		1,700		1,200		-			-		2,900
Depreciation and Amortization		10,700		8,700		24,000			-		43,400

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Three months ended March 31, 2012
Net Sales	$	1,025,300	$	418,300		$	75,900		$	-		$	1,519,500
Foreign Sales		613,900		405,900			3,600			-			1,023,400
Profit (Loss)		80,700		(76,000	)		(16,300	)		(4,100	)		(15,700	)
Assets		2,446,300		1,239,700			842,700			1,492,500			6,021,200
Long-Lived Asset Expenditures		7,500		-			-			-			7,500
Depreciation and Amortization		12,500		5,900			24,000			-			42,400

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other		Consolidated
Nine months ended March 31, 2013
Net Sales	$	3,459,500	$	1,309,700		$	85,500		$	-	$	4,854,700
Foreign Sales		2,014,900		626,400			-			-		2,641,300
Profit (Loss)		518,100		(62,500	)		(147,600	)		-		308,000
Assets		2,719,500		1,932,600			904,600			916,800		6,473,500
Long-Lived Asset Expenditures		10,900		19,300			-			-		30,200
Depreciation and Amortization		33,300		27,200			71,900			-		132,400

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
Nine months ended March 31, 2012
Net Sales	$	3,208,900	$	973,200		$	75,900		$	-		$	4,258,000
Foreign Sales		1,977,700		527,000			3,600			-			2,508,300
Profit (Loss)		341,300		(252,400	)		(48,600	)		(62,300	)		(22,000	)
Assets		2,446,300		1,239,700			842,700			1,492,500			6,021,200
Long-Lived Asset Expenditures		21,500		49,500			876,000			-			947,000
Depreciation and Amortization		36,700		68,900			36,000			-			141,600